- Home
- Publications
- Publication Search
- Publication Details
Title
What is the optimal neo-adjuvant treatment for liver metastasis?
Authors
Keywords
-
Journal
Therapeutic Advances in Medical Oncology
Volume 5, Issue 4, Pages 221-234
Publisher
SAGE Publications
Online
2013-04-19
DOI
10.1177/1758834013485111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)
- (2012) Halfdan Sorbye et al. ANNALS OF SURGERY
- Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature
- (2012) Alexander Stein et al. BMC CANCER
- Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study
- (2012) Kjell Magne Tveit et al. JOURNAL OF CLINICAL ONCOLOGY
- The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus
- (2012) R. Adam et al. ONCOLOGIST
- Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study
- (2011) C. Bokemeyer et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
- (2011) Timothy S Maughan et al. LANCET
- Cetuximab Plus FOLFIRINOX (ERBIRINOX) as First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial
- (2011) E. Assenat et al. ONCOLOGIST
- Is Perioperative Chemotherapy Useful for Solitary, Metachronous, Colorectal Liver Metastases?
- (2010) Rene Adam et al. ANNALS OF SURGERY
- Concomitant Extrahepatic Disease in Patients With Colorectal Liver Metastases
- (2010) René Adam et al. ANNALS OF SURGERY
- Liver Resection for Colorectal Metastases in Presence of Extrahepatic Disease: Results from an International Multi-institutional Analysis
- (2010) Carlo Pulitanò et al. ANNALS OF SURGICAL ONCOLOGY
- Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases
- (2010) D. A. Wicherts et al. BRITISH JOURNAL OF SURGERY
- Liver resection of colorectal metastases in elderly patients
- (2010) R. Adam et al. BRITISH JOURNAL OF SURGERY
- Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases
- (2010) D. A. Wicherts et al. BRITISH JOURNAL OF SURGERY
- The Timing of Chemotherapy and Surgery for the Treatment of Colorectal Liver Metastases
- (2010) Bernard Nordlinger et al. Clinical Colorectal Cancer
- Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
- (2010) Jean-Yves Douillard et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial
- (2010) Gianluca Masi et al. LANCET ONCOLOGY
- Diagnostic Imaging of Colorectal Liver Metastases with CT, MR Imaging, FDG PET, and/or FDG PET/CT: A Meta-Analysis of Prospective Studies Including Patients Who Have Not Previously Undergone Treatment
- (2010) Maarten Christian Niekel et al. RADIOLOGY
- A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer
- (2009) M. Ychou et al. ANNALS OF ONCOLOGY
- Synchronous Colorectal Liver Metastases: Is It Time to Reconsider Traditional Paradigms of Management?
- (2009) Srinevas K. Reddy et al. ANNALS OF SURGICAL ONCOLOGY
- A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases
- (2009) Oliver F Bathe et al. BMC CANCER
- Survival after hepatic resection of colorectal cancer metastases
- (2009) Douglas J. Robertson et al. CANCER
- Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases
- (2009) Yun Shin Chun JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Simultaneous Versus Staged Resection for Synchronous Colorectal Cancer Liver Metastases
- (2009) Robert C.G. Martin et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
- (2009) Gunnar Folprecht et al. LANCET ONCOLOGY
- Clinical Outcomes Associated with Bevacizumab-Containing Treatment of Metastatic Colorectal Cancer: The BRiTE Observational Cohort Study
- (2009) M. Kozloff et al. ONCOLOGIST
- Benefits of Contrast-Enhanced Sonography for the Detection of Liver Lesions: Comparison with Histologic Findings
- (2008) Linda Chami et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
- (2008) Birgit Gruenberger et al. BMC CANCER
- Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials
- (2008) Emmanuel Mitry et al. JOURNAL OF CLINICAL ONCOLOGY
- Is Hepatic Resection Justified After Chemotherapy in Patients With Colorectal Liver Metastases and Lymph Node Involvement?
- (2008) René Adam et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741
- (2008) Hanna K. Sanoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
- (2008) Carsten Bokemeyer et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More